II. Background

  1. Misuse is increasing in 2016-2018 and associated with Arrhythmia and Cardiac Arrest deaths
  2. Users refer to Imodium as "Poor-man's Methadone"
  3. Users take more than 64 mg (4 fold higher than the total daily dose) to get high
    1. Loperamide is highly albumin bound
    2. High doses saturate available albumin, and unbound Loperamide may cross the blood brain barrier
  4. P-Glycoprotein prevents Loperamide from crossing blood-brain barrier (and also stimulates GI excretion)
    1. Abusers often coningest P-Glycoprotein Inhibitors (e.g. Cimetidine, Quinine) to enhance CNS effects
  5. References
    1. (2016) Presc Lett 23(7): 37-8

III. Signs

  1. Somnolence
  2. Respiratory depression
  3. Syncope
  4. Cardiac Dysrhythmia
    1. See EKG below

IV. Labs

  1. Basic metabolic panel
  2. Serum Calcium
  3. Serum Magnesium

V. Diagnostics: Electrocardiogram

  1. Premature Ventricular Contractions
  2. QRS Widening may be significant (e.g. >160 ms)
  3. QTc Prolongation may be significant (e.g. >700 ms)
  4. Torsades de Pointes

VI. Management

  1. Consider Gastric Decontamination with Activated Charcoal
    1. Indicated for early presentation of massive ingestion (e.g. 1 mg/kg)
  2. CNS depression (including respiratory depression)
    1. Naloxone
  3. Treat Arrhythmias
    1. Sodium Bicarbonate for QRS Widening
    2. QT Prolongation with risk of Torsades de Pointes
      1. See Torsades de Pointes for management
  4. Disposition
    1. Asymptomatic or improving patients discharged after 6 hours from time of ingestion
    2. Admit patients with Dysrhythmias or other significant findings

VII. References

  1. Lasoff (2016) Crit Dec Emerg Med 30(12): 24
  2. Swadron and Nordt in Herbert (2016) EM:Rap 17(1): 3
  3. Swadron and Nordt in Herbert (2018) EM:Rap 18(6): 8
  4. Eggleston (2017) Ann Emerg Med 69(1):83-6 +PMID:27140747 [PubMed]

Images: Related links to external sites (from Bing)

Related Studies